Jump to content

Weekly and monthly pills in development.

Recommended Posts




A once-a-week pill containing risperidone, an antipsychotic used for people with schizophrenia and bipolar disorder, is to go into clinical trials this year, the company said, and is expected to be submitted for approval by the US Food and Drug Administration (FDA) by the end of next year, with approval hoped for by the end of 2024.


Link to comment
Share on other sites


  • Create New...